Articles published by LEO Pharma






LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland
November 14, 2024
From LEO Pharma
Via Business Wire


Germany Becomes the First Country to Launch LEO Pharma’s Anzupgo® (delgocitinib) Cream
October 15, 2024
From LEO Pharma
Via Business Wire

LEO Pharma Commits to Net-Zero Greenhouse Gas Emissions by 2050
October 11, 2024
From LEO Pharma
Via Business Wire


LEO Pharma Submits New Drug Application for Enstilar® for Adults with Plaque Psoriasis in China
September 27, 2024
From LEO Pharma
Via Business Wire















Annual Report 2023: LEO Pharma Delivers 10% Revenue Growth and Returns to Positive EBITDA
February 29, 2024
From LEO Pharma
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.